(Q44074218)

29 November 2017

Hormonal, renal, hemodynamic responses to acute neutral endopeptidase inhibition in heart transplant patients (English)

1 reference

29 November 2017

1 reference

François Piquard

1

1 reference

29 November 2017

Ruddy Richard

2

1 reference

29 November 2017

Anne Charloux

3

1 reference

29 November 2017

Stephane Doutreleau

4

1 reference

29 November 2017

Thierry Hannedouche

5

1 reference

29 November 2017

Gabrielle Brandenberger

6

1 reference

29 November 2017

Bernard Geny

7

1 reference

29 November 2017

language of work or name

English

0 references

publication date

1 August 2002

1 reference

Journal of Applied Physiology

29 November 2017

1 reference

29 November 2017

93

1 reference

29 November 2017

2

1 reference

29 November 2017

569-575

1 reference

Comparison of candoxatril and atrial natriuretic factor in healthy men. Effects on hemodynamics, sympathetic activity, heart rate variability, and endothelin.

29 November 2017

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00027.2002

Plasma A- and B-type natriuretic peptides: physiology, methodology and clinical use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00027.2002

Diverse biological actions of atrial natriuretic peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00027.2002

Clearance receptors and endopeptidase 24.11: equal role in natriuretic peptide metabolism in conscious sheep

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00027.2002

Inhibition of neutral endopeptidase causes vasoconstriction of human resistance vessels in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00027.2002

Enhanced brain natriuretic peptide response to peak exercise in heart transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00027.2002

Enhanced natriuretic response to neutral endopeptidase inhibition in heart-transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00027.2002

Cardiac natriuretic peptides during exercise and training after heart transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00027.2002

Potentiation of urinary atrial natriuretic peptide interferes with macula densa function

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00027.2002

Role of endopeptidase-24.11 in the inactivation of atrial natriuretic peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00027.2002

Endothelin-A-Receptors in Human Aorta and Pulmonary Arteries are Downregulated in Patients With Cardiovascular Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00027.2002

The effect of the neutral endopeptidase inhibitor drug, candoxatril, on circulating levels of two of the most potent vasoactive peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00027.2002

Effect of neutral endopeptidase inhibition on the actions of adrenomedullin and endothelin-1 in resistance arteries from patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00027.2002

Endothelins: multifunctional renal peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00027.2002

Urinary cGMP as biological marker of the renal activity of atrial natriuretic factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00027.2002

Inhibition of Neutral Endopeptidase Potentiates the Effects of Atrial Natriuretic Peptide on Acute Cyclosporin-Induced Nephrotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00027.2002

Renal, hemodynamic and neurohormonal effects of atrial natriuretic factor in cardiac allograft recipients treated with cyclosporin A

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00027.2002

10.1152/JAPPLPHYSIOL.00027.2002

21 January 2018

Identifiers

DOI

1 reference

29 November 2017

1 reference